| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Cytarabine | GDSC1000 | pan-cancer | AAC | -0.13 | 0.0005 |
| mRNA | Erlotinib | UHNBreast | pan-cancer | AAC | 0.8 | 0.0006 |
| mRNA | lapatinib | CCLE | pan-cancer | AAC | 0.16 | 0.0007 |
| mRNA | SRT-1720 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.001 |
| mRNA | CHIR-99021 | GDSC1000 | pan-cancer | AAC | -0.1 | 0.001 |
| mRNA | Bexarotene | GDSC1000 | pan-cancer | AAC | -0.11 | 0.002 |
| mRNA | SCH-79797 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.002 |
| mRNA | NVP-BEZ235 | GDSC1000 | pan-cancer | AAC | -0.11 | 0.002 |
| mRNA | Irinotecan | CCLE | pan-cancer | AAC | 0.17 | 0.002 |
| mRNA | BRD-K04800985 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.004 |